微创手术与食管切除术后并发症减少相关
基于美国外科医师学会国家手术质量改进计划数据库(2007-2018年)的回顾性分析,纳入13457例食管切除术,其中开放手术11202例(83.2%)、微创手术2255例(16.8%)。微创手术患者总体并发症、呼吸系统并发症、尿路感染、肾脏并发症、出血并发症及非家庭出院的风险均较低,且住院时间更短(9.7天 vs 13.2天,P<.0001)。
要点
- 微创食管切除术与较低的总体并发症风险相关(OR 0.68,95%CI 0.62-0.75)。
- 微创手术患者出血并发症风险明显降低(OR 0.36,95%CI 0.30-0.43),住院时间更短(9.7天 vs 13.2天)。
- 在微创技术中,Ivor Lewis术式的总体并发症和感染发生率均低于微创经裂孔和McKeown术式。
核心结论
- 接受微创食管切除术的患者术后并发症发生率较低,且不受食管切除术式影响。
- 微创入路与三种常见食管切除术式之间并发症变异减少相关。
研究设计与样本
- 回顾性分析美国外科医师学会国家手术质量改进计划数据库(2007-2018年)。
- 通过现行操作术语代码识别食管切除术,按手术技术(Ivor Lewis、经裂孔、McKeown)和手术入路(微创 vs 开放)分组。
- 共分析13457例食管切除术:开放手术11202例(83.2%),微创手术2255例(16.8%)。
- 术式分布:Ivor Lewis 7611例(56.6%),经裂孔3348例(24.9%),McKeown 2498例(18.6%)。
- 比较12项术后并发症,对显著并发症采用多因素logistic回归进行风险调整。
主要发现
- 在12项风险调整后并发症中,不同手术技术之间有6项存在显著差异。
- 在微创技术之间比较,12项并发症中仅2项存在显著差异:总体并发症(微创Ivor Lewis 30.5%,微创经裂孔43.4%,微创McKeown 40.3%,P = .0009)和感染(微创Ivor Lewis 15.4%,微创经裂孔26.0%,微创McKeown 25.3%,P = .0003)。
- 微创手术患者总体并发症风险较低(OR 0.68,95%CI 0.62-0.75)。
- 微创手术患者呼吸系统并发症风险较低(OR 0.77,95%CI 0.68-0.87),尿路感染风险较低(OR 0.61,95%CI 0.43-0.88),肾脏并发症风险较低(OR 0.52,95%CI 0.34-0.81),出血并发症风险较低(OR 0.36,95%CI 0.30-0.43),非家庭出院风险较低(OR 0.54,95%CI 0.45-0.64)。
- 微创手术患者住院时间更短(9.7天 vs 13.2天,P < .0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although some studies have compared esophagectomy outcomes by technique or approach, there is opportunity to strengthen our knowledge surrounding these outcomes. We aimed to perform a comprehensive comparison of esophagectomy postoperative complications. METHODS: We retrospectively reviewed the American College of Surgeons National Surgical Quality Improvement Program database (2007-2018). Esophagectomies were identified using Current Procedural Terminology codes and grouped by operative technique (Ivor Lewis, transhiatal, McKeown) and surgical approach (minimally invasive vs open esophagectomy). Twelve postoperative complications were compared. Significant complications underwent risk adjustment using multivariate logistic regression. RESULTS: Analysis was performed on 13,457 esophagectomies: 11,202 (83.2%) open and 2255 (16.8%) minimally invasive. There were 7611 (56.6%) Ivor Lewis, 3348 (24.9%) transhiatal, and 2498 (18.6%) McKeown procedures. There were significant differences among the surgical techniques in 6 of 12 risk-adjusted complications. When comparing the outcomes of minimally invasive techniques, there were only significant differences in 2 of 12 complications: overall morbidity (minimally invasive Ivor Lewis 30.5%, minimally invasive transhiatal 43.4%, minimally invasive McKeown 40.3%, P = .0009) and infections (minimally invasive Ivor Lewis 15.4%, minimally invasive transhiatal 26.0%, minimally invasive McKeown 25.3%, P = .0003). Patients who underwent minimally invasive surgery were less likely to have overall morbidity (odds ratio, 0.68; 95% confidence interval, 0.62-0.75), respiratory complications (odds ratio, 0.77; 95% confidence interval, 0.68-0.87), urinary tract infection (odds ratio, 0.61; 95% confidence interval, 0.43-0.88), renal complications (odds ratio, 0.52; 95% confidence interval, 0.34-0.81), bleeding complications (odds ratio, 0.36; 95% confidence interval, 0.30-0.43), and nonhome discharge (odds ratio, 0.54; 95% confidence interval, 0.45-0.64), and had shorter length of stay (9.7 vs 13.2 days, P < .0001). CONCLUSIONS: Patients undergoing minimally invasive esophagectomy have lower rates of postoperative complications regardless of esophagectomy techniques. The minimally invasive approach was associated with reduced complication variance among 3 common esophagectomy techniques.
引用
- Dyas AR, Stuart CM, Bronsert MR, et al. Minimally invasive surgery is associated with decreased postoperative complications after esophagectomy. J Thorac Cardiovasc Surg. 2022. PMID: 36577613. doi:10.1016/j.jtcvs.2022.11.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。